(Q44697565)

English

Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjögren’s syndrome: a pilot study

scientific article published in November 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Evaluation of histologic, serologic, and clinical changes in response to abatacept treatment of primary Sjögren’s syndrome: a pilot study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

6

object named as

Peter M Villiger

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Sabine Adler

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Meike Körner

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Frauke Förger

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Dörte Huscher

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Marco-Domenico Caversaccio

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

publication date

1 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Arthritis Care and Research

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

65

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1862-1868

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Effect of cyclosporin A (CyA) on the immunopathological lesion of the labial minor salivary glands from patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Local delivery of AAV2-CTLA4IgG decreases sialadenitis and improves gland function in the C57BL/6.NOD-Aec1Aec2 mouse model of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Safety and usefulness of minor salivary gland biopsy: retrospective analysis of 502 procedures performed at a single center.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Regulatory T cells in human autoimmune thyroid disease.

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Foxp3+ T-regulatory cells in Sjogren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Class-switched B cells display response to therapeutic B-cell depletion in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants

1 reference

https://api.crossref.org/works/10.1002%2FACR.22052

21 January 2018

Identifiers

10.1002/ACR.22052

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44697565&oldid=2032836149"